SAYSD1

Across TCGA pan-cancer cohorts, SAYSD1 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of SAYSD1’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where SAYSD1 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types SAYSD1 is over-expressed in tumor, although a few such as PDAC and CCRCC show the opposite, repressed pattern.

PDAC, CCRCC, and LSCC are the cancer types where SAYSD1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SAYSD1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PDAC	All	All	−0.826	<.001	6	view →
CCRCC	Male	III,IV	−0.535	<.001	6	view →
LSCC	Male	II,III,IV	−0.212	<.001	5	view →
LUAD	Female	III,IV	+0.462	.012	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

SAYSD1–PDAC

Open the PDAC breakdown →